Judith Ochs - Concepedia

Author

Judith Ochs

St. Jude Children's Research Hospital

Also Known As

J Ochs, JUDITH OCHS, Judith J Ochs, Judith J. Ochs, Judith Ochs, JudithJ. Ochs

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

St. Jude Children's Research Hospital University of Tennessee Health Science Center The University of Texas MD Anderson Cancer Center Palmetto Hematology Oncology AstraZeneca (Brazil)

About

Judith Ochs is an author at St. Jude Children's Research Hospital specializing in medicine, pediatrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	650
2	Health Sciences	6	6	524
3	Education	3	3	88
4	Child Development	3	3	88
5	Social Sciences	1	1	31

Judith Ochs

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer Mark G. Kris, Ronald B. Natale, Roy S. Herbst, JAMA	2003	2.5K
Bone Marrow Transplants from HLA-Identical Siblings as Compared with Chemotherapy for Children with Acute Lymphoblastic Leukemia in a Second Remission A. John Barrett, Mary M. Horowitz, Brad H. Pollock, New England Journal of Medicine	1994	236
Intensive Retreatment of Childhood Acute Lymphoblastic Leukemia in First Bone Marrow Relapse Gaston K. Rivera, George R. Buchanan, James M. Boyett, New England Journal of Medicine Hematological MalignancyOncologyPediatric HematologyBone Marrow RelapseMalignant Blood Disorder	1986	148
Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis June S. Taylor, J. William Langston, Wilburn E. Reddick, International Journal of Radiation OncologyBiologyPhysics Clinical ValueBrain LesionGliomaMagnetic Resonance ImagingNeuro-oncology	1996	138
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non-Small Cell Lung Cancer Mark G. Kris, Ronald B. Natale, Roy S. Herbst, MedicineCancer ManagementSymptomatic PatientsPartial Radiographic ResponsesClinical Trials	2017	97
Removal of methotrexate, leucovorin, and their metabolites by combined hemodialysis and hemoperfusion Mary V. Relling, F. Bruder Stapleton, Judith Ochs, Cancer	1988	82
Predominance of Pilocytic Histology in Dorsally Exophytic Brain Stem Tumors Ziad Khatib, Richard L. Heideman, Edward H. Kovnar, Pediatric Neurosurgery	1994	78
SEIZURES IN CHILDHOOD LYMPHOBLASTIC LEUKAEMIA PATIENTS Judith Ochs, Ching-Hong Pui, Clara Mason, The Lancet Hematological MalignancyMalignant Blood DisorderHematologyPediatricsPediatric Hematology	1984	77
High‐dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude total therapy study X Minnie Abromowitch, Judith Ochs, Ching‐Hon Pui, Medical and Pediatric Oncology ImmunologyPharmacotherapyImmunotherapyMyeloid NeoplasiaHematological Malignancy	1988	68
Computed tomography brain scans in children with acute lymphocytic leukemia receiving methotrexate alone as central nervous system prophylaxis Judith Ochs, Paul S. Berger, Martin L. Brecher, Cancer	1980	61

Page 1